Serine threonine-specific protein kinase

Results: 6



#Item
1Downloaded from http://rsbm.royalsocietypublishing.org/ on August 19, 2016  Yasutomi Nishizuka. 12 July 1932 −− 4 November 2004: Elected ForMemRS 1990 Hirohei Yamamura and Shun-Ichi Nakamura Biogr. Mems Fell. R. Soc.

Downloaded from http://rsbm.royalsocietypublishing.org/ on August 19, 2016 Yasutomi Nishizuka. 12 July 1932 −− 4 November 2004: Elected ForMemRS 1990 Hirohei Yamamura and Shun-Ichi Nakamura Biogr. Mems Fell. R. Soc.

Add to Reading List

Source URL: rsbm.royalsocietypublishing.org

Language: English
2Atypical Protein Kinases (aPKs) Supplemental Online Material for Manning et al (Science 298:Atypical protein kinases lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally t

Atypical Protein Kinases (aPKs) Supplemental Online Material for Manning et al (Science 298:Atypical protein kinases lack sequence similarity to the ePK domain HMM profile, but have been shown experimentally t

Add to Reading List

Source URL: kinase.com

Language: English - Date: 2014-03-08 21:58:29
3Genomic overview of protein kinases* Gerard Manning§, Razavi-Newman Center for Bioinformatics, Salk Institute for Biological Studies, La Jolla, CaliforniaUSA Table of Contents 1. Introduction ....................

Genomic overview of protein kinases* Gerard Manning§, Razavi-Newman Center for Bioinformatics, Salk Institute for Biological Studies, La Jolla, CaliforniaUSA Table of Contents 1. Introduction ....................

Add to Reading List

Source URL: www.wormbook.org

Language: English - Date: 2013-06-28 18:56:21
4A historical overview of protein kinases and their targeted small molecule inhibitors

A historical overview of protein kinases and their targeted small molecule inhibitors

Add to Reading List

Source URL: www.brimr.org

Language: English - Date: 2015-08-01 12:59:02
5SuperGen PIM Kinase Presentations at AACR DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today a

SuperGen PIM Kinase Presentations at AACR DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today a

Add to Reading List

Source URL: astx.com

Language: English
6Japan-Mexico WS  Abstract of Presentation Presentation Title: PROTEIN KINASE C MODULATES WNT SIGNALING IN COLON TUMORAL CELL LINES.

Japan-Mexico WS Abstract of Presentation Presentation Title: PROTEIN KINASE C MODULATES WNT SIGNALING IN COLON TUMORAL CELL LINES.

Add to Reading List

Source URL: www.jst.go.jp

Language: English - Date: 2009-06-30 21:15:57